Which drugs are most likely to be approved in Lentivirus Infections?

Lentivirus Infections disease is an indication for drug development with over 520 pipeline drugs currently active according to GlobalData.

Emergent BioSolutions CEO Robert Kramer announces retirement

Robert Kramer, the CEO of contract manufacturer Emergent BioSolutions, is retiring after more than two decades, including leading the company through a sometimes-turbulent Covid-19 pandemic.

June 28, 2023

GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?

Next week, 50 medical experts from the Karolinska Institutet in Stockholm will meet to award the 2023 Nobel Prize for Physiology or Medicine. The vote

September 30, 2023

Wealthy nations might be reaching a life expectancy limit, study suggests — at least for now

Over the past 150 years, humanity has unleashed unimaginable energy by splitting atoms and developed machines that allow us to soar through the skies. But

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.